Weigao Orthopaedic(688161)2025-02-27 07:50Financial Performance - Total revenue for 2024 reached RMB 145,218.62 million, an increase of 13.14% compared to the previous year[3] - Net profit attributable to shareholders was RMB 22,181.33 million, reflecting a growth of 97.49% year-on-year[5] - Operating profit for the period was RMB 27,174.21 million, up 107.61% from the previous year[6] - Basic earnings per share increased to RMB 0.55, a rise of 96.43% compared to the same period last year[6] Assets and Equity - Total assets at the end of the reporting period were RMB 494,699.42 million, a decrease of 2.93% from the beginning of the period[4] - Shareholders' equity attributable to the parent company grew to RMB 395,158.15 million, an increase of 2.14%[4] Strategic Initiatives - The company implemented a strategy focusing on orthopedic consumables procurement, enhancing market share and customer coverage[5] - The company is advancing new business lines and improving brand influence through overseas product registrations[6] - The company optimized marketing structure and inventory management, leading to reduced sales expense ratio and improved supply chain efficiency[6] Reporting Accuracy - There are no significant uncertainties affecting the accuracy of the performance report[7]